What do you think the PPS will be if the only info we get from ASCO, is that they are still waiting for 233 OS events?
Anybody?

I contacted TDA yesterday. This was the exchange.

On 04/18/17 9:54 AM Message Center Client Services wrote:

Hello xxxxxxxx,

Thank you for the e-mail! I understand the frustrations with the news feed and how you can view it as being biased. I wish there was a better way we can filter the feeds but as you know they do come from a number of third party providers and are out of our control. I have submitted a request to our data team to get in contact with the third party providers and see if we can makes some positive changes in the news feed.

If you have any additional questions or concerns please don't hesitate to ask.

Kind regards,

Pasquale Ricchio
Client Liaison
866.839.1100

thinkorswim, Division of TD AMERITRADE, Inc.
600 west chicago avenue, suite #100
chicago, IL 60654-2597

Member FINRA | SIPC
trademark, all rights reserved




Original Message Follows:
------------------------

Form Message

FULL_NAME: Benxxxxxxxxxx
ACCOUNT_TITLE: xxxxxxxxxxxxx
USERID: xxxxxxxxxx
ACCOUNT_NUMBER: xxxxxxxxxxxxxx
INQUIRY: TOS
User-Agent: Mozilla/5.0 (Windows NT 6.1; rv:52.0) Gecko/20100101 Firefox/52.0
ENVIRONMENT: invest.ameritrade.com

-------------------------------------------------

The news feed for a stock I am trading(NWBO), under the live news feed has a article/blurb about a tweet from some analyst as news. Though no mention of the 10K that was just released!
Extremely Biased and unprofessional. Even if the news feed that TD Ameritrade uses for this platform is from an independent source, that does not matter. It is a direct reflection on TD Ameritrade!
Very disappointing.

has anyone seen this article yet?
https://www.americanbankingnews.com/2017/04/17/northwest-biotherapeutics-nwbo-earning-very-favorable-news-coverage-alphaone-reports.html

Is this the only stock you people ever invested in? Today's price action is the market having a knee-jerk reaction to a 10K that really had very little new or unexpected info in it. It will likely be a down day, but by the end of the week it will be back at .24 or .25, possibly by tomorrow. IMHO.

I hope you are correct. Soon we will all know. Thanks.

WHY,OH WHY, did you not tell use this before? I would have sold all my shares long ago! You are clearly the expert here... LOL

Beach, Maybe your assumption that NWBO knows with 90% certainty what the final outcome will be is the problem.
How would NWBO act if they feel that this trial is going to be a "Photo Finish"?
IMO, the way NWBO is acting, points to a trial that could go either way. They are likely doing everything in their power to tip the scales for approval. As we all would expect them to do.

Thanks to everyone who took the time to respond. Thank you Vator, your explanation seems to make good sense, and explains the situation. Good luck to all who are long on NWBO.

I understand that, sorry for the confusion. What if this was used during the screening process of some of the patients?
Again, I stress, this is just a thought, not making any claims!

I know this is a stretch. It seems that the hold on the P3 trial was never explained. There is no FDA form 483 listed anywhere for NWBO. My understanding is that this form should have been filed by the FDA in order to put a hold on the trial. At the very least there should have been a warning letter issued by the FDA to NWBO, for what ever caused there concern. I could not even find record of a warning from the FDA.

The Hold was placed on Aug 21st 2015, I believe that is correct.
On Aug 24th 2015, the FDA issued a warning letter to Rapid Diagnostics, Division of MP Biomedicals, Llc. That between February 19 and March 2, 2015, an investigator from the United States Food and Drug Administration (FDA) determined that your firm manufactures in vitro diagnostic devices including the OneStep Myoglobin RapidCard InstaTest. Under section 201(h) of the Federal Food, Drug, and Cosmetic Act (the Act), 21 U.S.C. § 321(h), these products are devices because they are intended for use in the diagnosis of disease or other conditions or in the cure, mitigation, treatment, or prevention of disease, or to affect the structure or function of the body. Because, This inspection revealed that the OneStep Myoglobin RapidCard InstaTest device is adulterated under section 501(f)(1)(B) of the Act, 21 U.S.C. 351(f)(1)(B), because you do not have an approved application for premarket approval (PMA) in effect pursuant to section 515(a) of the Act, 21 U.S.C. 360e(a), or an approved application for an investigational device exemption (IDE) under section 520(g) of the Act, 21 U.S.C. 360j(g). The OneStep Myoglobin RapidCard InstaTest device is also misbranded under section 502(o) the Act, 21 U.S.C. 352(o), because you did not notify the agency of your intent to introduce the device into commercial distribution in that a notice or other information regarding the new intended use of the device was not provided to the FDA as required by section 510(k), 21 U.S.C. 360(k), and 21 C.F.R. 807.81(a)(3)(ii). For a device requiring premarket approval,

What would happen if this piece of equipment was being used at some of the P3 test sites? What if the company(Rapid Diagnostics, Division of MP Biomedicals, Llc) did not want to release this info at all to the public, even after it was corrected? They may not have to release any public info because it was only a warning and it was corrected. Why leave the hold on our trial? I don't know.

I know this is a real stretch.

Here is the link to the FDA warning letter, if anyone cares.

https://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2015/ucm459598.htm

Do any of the medical professionals here know what a immunochromatography based
one step in vitro test is used for? Could it be used at the NWBO clinical test sites? I am sorry if this is odd or vague, but I did not know were else to ask this question, and get an answer from someone familiar with the ongoing trial.

Thanks